Citius Pharmaceuticals, Inc. (CTXR)
0.5817
-0.02
(-3.37%)
USD |
NASDAQ |
Sep 04, 16:00
0.5817
0.00 (0.00%)
After-Hours: 16:02
Citius Pharmaceuticals Shareholders Equity (Quarterly) : 66.61M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.61M |
| March 31, 2026 | 61.54M |
| December 31, 2025 | 79.96M |
| September 30, 2025 | 67.55M |
| June 30, 2025 | 65.06M |
| March 31, 2025 | 60.66M |
| December 31, 2024 | 65.41M |
| September 30, 2024 | 70.08M |
| June 30, 2024 | 85.68M |
| March 31, 2024 | 79.37M |
| December 31, 2023 | 84.73M |
| September 30, 2023 | 90.83M |
| June 30, 2023 | 97.70M |
| March 31, 2023 | 91.21M |
| December 31, 2022 | 100.43M |
| September 30, 2022 | 102.83M |
| June 30, 2022 | 109.74M |
| March 31, 2022 | 117.60M |
| December 31, 2021 | 123.96M |
| September 30, 2021 | 132.18M |
| June 30, 2021 | 136.68M |
| March 31, 2021 | 125.16M |
| December 31, 2020 | 25.20M |
| September 30, 2020 | 33.67M |
| June 30, 2020 | 28.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 22.44M |
| December 31, 2019 | 20.38M |
| September 30, 2019 | 24.38M |
| June 30, 2019 | 21.51M |
| March 31, 2019 | 20.87M |
| December 31, 2018 | 24.18M |
| September 30, 2018 | 27.87M |
| June 30, 2018 | 21.64M |
| March 31, 2018 | 23.50M |
| December 31, 2017 | 25.86M |
| September 30, 2017 | 21.95M |
| June 30, 2017 | 11.59M |
| March 31, 2017 | 13.99M |
| December 31, 2016 | 15.16M |
| September 30, 2016 | 16.77M |
| June 30, 2016 | 18.16M |
| March 31, 2016 | 20.43M |
| December 31, 2015 | -1.590M |
| September 30, 2015 | -0.6352M |
| June 30, 2015 | -1.180M |
| March 31, 2015 | -0.918M |
| December 31, 2014 | -0.8235M |
| September 30, 2014 | |
| June 30, 2014 | -0.0314M |
| March 31, 2014 | -0.0251M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Citius Oncology, Inc. | 40.38M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 142.26M |
| Total Liabilities (Quarterly) | 66.35M |
| Debt to Equity Ratio | 0.1077 |
| Current Ratio | 0.839 |
| Net Debt Paydown Yield | -7.53% |